Shape the future of consumer health.
Vice President, Global R&D/RWE Services, IQVIA Consumer Health
IQVIA Consumer Health experts Dr. Volker Spitzer, Sarah Rickwood and Matt Stewart explore the rapidly evolving landscape of obesity management and the expanding impact of GLP-1 therapies.
As these breakthrough treatments move into the mainstream, the discussion focuses on nutrition in obesity care — the critical, and often overlooked, factor that supports long-term patient outcomes, treatment success, and sustainable health results.
Key discussions you won’t want to miss
Vice President, Global R&D/RWE Services, IQVIA Consumer Health
Vice President, Thought Leadership, IQVIA EMEA
Associate Director, Global Marketing, IQVIA Consumer Health
00:42 – The changing landscape of obesity Care
How the end of GLP-1 shortages and growing access in 2025 are transforming obesity management at scale.
02:10 – Nutrition’s expanding role in GLP-1 therapy success
Exploring why structured nutrition guidance is essential to maintain results and manage long-term adherence.
04:35 – Evidence on nutrient intake in GLP-1 users
Data showing reduced calorie and micronutrient consumption — and how nutrient-dense foods and supplements can help address these gaps.
06:20 – Micronutrients to monitor
Key focus areas including B12, iron, calcium, vitamin D and magnesium — and why proactive monitoring supports safety and persistence..
08:05 – Evidence-based nutrition targets
Best-practice data on protein, fibre, hydration, and supplementation — and how these support metabolic stability.
10:40 – Integrating nutrition into care pathways
Practical frameworks for healthcare professionals to pair pharmacotherapy with structured nutrition and follow-up.
13:10 – Opportunities for nutrition innovation
Opportunities for the medical and food industries to develop nutrient-dense, high-protein products tailored for GLP-1 users.
16:00 – The role of pharmacies and digital support
How digital tools, pharmacies, and refill models are helping track adherence and sustain outcomes during GLP-1 therapy.
18:20 – Practical framework for nutrition support
Key components of the “Screen–Plan–Supplement–Strengthen” model and the importance of regular touchpoints.
20:10 – Closing insights and best practice
Summary of data-led next steps for healthcare, nutrition, and pharmacy partners to improve long-term outcomes.
You can download the full transcript here.
Want to explore how nutrition strategies can enhance GLP-1 treatment outcomes? Connect with our experts to learn how IQVIA Consumer Health can support your next initiative.
Gain expert insights into the nutritional implications of GLP-1 therapies and their impact on obesity management. Explore how nutrition influences patient outcomes, supports long-term success, and creates new opportunities for growth in obesity care.
Review the slides from our expert discussion covering the changing landscape of obesity care, nutrient shortfalls in GLP-1 users, the first 90 days of therapy, and opportunities for innovation across the health and nutrition ecosystem.
Shape the future of consumer health.
Compelling claims to capture the minds of consumers
Navigate regulatory pathways with confidence